Hugh M Cole - Net Worth and Insider Trading
Hugh M Cole Net Worth
The estimated net worth of Hugh M Cole is at least $924,639 dollars as of 2024-12-27. Hugh M Cole is the SVP, Chief Business Officer of ARIAD Pharmaceuticals Inc and owns about 29,916 shares of ARIAD Pharmaceuticals Inc (ARIA) stock worth over $717,685. Hugh M Cole is also the COO of Jounce Therapeutics Inc and owns about 110,082 shares of Jounce Therapeutics Inc (JNCE) stock worth over $206,954. Details can be seen in Hugh M Cole's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Hugh M Cole has not made any transactions after 2023-01-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Hugh M Cole
Hugh M Cole Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Hugh M Cole owns 3 companies in total, including Jounce Therapeutics Inc (JNCE) , Astria Therapeutics Inc (ATXS) , and ARIAD Pharmaceuticals Inc (ARIA) .
Click here to see the complete history of Hugh M Cole’s form 4 insider trades.
Insider Ownership Summary of Hugh M Cole
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| JNCE | Jounce Therapeutics Inc | 2023-01-10 | Chief Business Officer |
| ATXS | Astria Therapeutics Inc | 2020-06-11 | director |
| ARIA | ARIAD Pharmaceuticals Inc | 2017-02-16 | SVP & Chief Business Officer |
Hugh M Cole Latest Holdings Summary
Hugh M Cole currently owns a total of 2 stocks. Among these stocks, Hugh M Cole owns 29,916 shares of ARIAD Pharmaceuticals Inc (ARIA) as of June 28, 2016, with a value of $717,685 and a weighting of 77.62%. Hugh M Cole also owns 110,082 shares of Jounce Therapeutics Inc (JNCE) as of January 10, 2023, with a value of $206,954 and a weighting of 22.38%.
Latest Holdings of Hugh M Cole
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ARIA | ARIAD Pharmaceuticals Inc | 2016-06-28 | 29,916 | 23.99 | 717,685 |
| JNCE | Jounce Therapeutics Inc | 2023-01-10 | 110,082 | 1.88 | 206,954 |
Holding Weightings of Hugh M Cole
Hugh M Cole Form 4 Trading Tracker
According to the SEC Form 4 filings, Hugh M Cole has made a total of 0 transactions in ARIAD Pharmaceuticals Inc (ARIA) over the past 5 years. The most-recent trade in ARIAD Pharmaceuticals Inc is the sale of 6,012 shares on June 28, 2016, which brought Hugh M Cole around $42,385.
According to the SEC Form 4 filings, Hugh M Cole has made a total of 6 transactions in Jounce Therapeutics Inc (JNCE) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Jounce Therapeutics Inc is the sale of 16,634 shares on January 10, 2023, which brought Hugh M Cole around $18,464.
Insider Trading History of Hugh M Cole
- 1
Hugh M Cole Trading Performance
GuruFocus tracks the stock performance after each of Hugh M Cole's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Hugh M Cole is -13.26%. GuruFocus also compares Hugh M Cole's trading performance to market benchmark return within the same time period. The performance of stocks bought by Hugh M Cole within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Hugh M Cole's insider trading performs compared to the benchmark.
Performance of Hugh M Cole
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.14 | | | | | |
| Relative Return to S&P 500(%) | -1.92 | | | | | |
Hugh M Cole Ownership Network
Hugh M Cole Owned Company Details
What does Jounce Therapeutics Inc do?
Who are the key executives at Jounce Therapeutics Inc?
Hugh M Cole is the Chief Business Officer of Jounce Therapeutics Inc. Other key executives at Jounce Therapeutics Inc include 10 percent owner Concentra Merger Sub, Inc. , 10 percent owner Concentra Biosciences, Llc , and director & CEO and President Richard /ca/ Murray .
Jounce Therapeutics Inc (JNCE) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Jounce Therapeutics Inc (JNCE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Jounce Therapeutics Inc (JNCE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Jounce Therapeutics Inc (JNCE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Jounce Therapeutics Inc Insider Transactions
Hugh M Cole Mailing Address
Above is the net worth, insider trading, and ownership report for Hugh M Cole. You might contact Hugh M Cole via mailing address: C/o Ariad Pharmaceuticals, Inc, 26 Landsdowne Street, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
